CTUK - CT PROGRESSIVE INCOME PLC

Portfolio Update

· RNS

Summary

CT UK Capital and Income Investment Trust's top ten holdings as of February 28, 2025, include Intermediate Capital (6.3%), AstraZeneca (6.0%), and OSB Group (5.6%), totaling 48.1%. The sector breakdown is led by Financials (30.7%) and Consumer Discretionary (16.0%). The fund has a net gearing of 3.6%.

Announcement

RNS Number : 6841B
CT UK Capital and Income Investment
21 March 2025
 

CT UK CAPITAL AND INCOME INVESTMENT TRUST PLC

 

Legal Entity Identifier: 21380052ETTRKV2A6Y19

 

 

All data as at 28 February 2025   

 

This data is available on the Company's website ctcapitalandincome.co.uk  

 

Top Ten Holdings

%

Intermediate Capital

6.3

AstraZeneca

6.0

OSB Group

5.6

RELX

5.3

Unilever

4.9

Beazley

4.7

LondonMetric Property

4.1

Burford Capital

4.1

Legal & General Group

3.7

Rio Tinto

3.4

Total

48.1

 

Sector Breakdown

%

Financials

 30.7

Consumer Discretionary

 16.0

Industrials

 13.1

Health Care

 9.9

Consumer Staples

 7.6

Real Estate

 5.2

Energy

 5.1

Basic Materials

 4.9

Utilities

 4.8

Telecommunications

 1.7

Technology

 1.0

Total

100.0

 

 

Note: All percentages are based on Gross Assets

 

Net Gearing

3.6%

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFUBFLFLEXLFBBK